P2 receptor-mediated effects on the open field behaviour of rats in comparison with behavioural responses induced by the stimulation of dopamine D2-like and by the blockade of ionotrophic glutamate receptors

Behavioural Brain Research

Volumn 149, Issue 2, 2004, Pages 197-208

  Kittner, H ^a   Hoffmann, E ^a   Krugel U ^a   Illes, P ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

2 MeSATP; CPP CNQX; Locomotor response; Nucleus accumbens; P2 receptors; PPADS; Quinpirole

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PURINE P2 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; QUINPIROLE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CELL STIMULATION; CONTROLLED STUDY; EVALUATION; INJECTION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RUNNING; STATISTICAL ANALYSIS;

EID: 1042301003     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00227-4     Document Type: Article

References (58)

1. Ahlenius S. Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors. Naunyn. Schmiedebergs Arch. Pharmacol. 345(5):1992;516-522.
2. Albin R.L., Makowiec R.L., Hollingsworth Z.R., Dure L.S., Penney J.B., Young A.B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46(1):1992;35-48.
3. Antoniou K., Kafetzopoulos E., Papadopoulou-Daifoti Z., Hyphantis T., Marselos M. D-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci. Biobehav. Rev. 23(2):1998;189-196.
4. Brown F., Campbell W., Mitchell P.J., Randall K. Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br. J. Pharmacol. 84(4):1985;853-860.
5. Brudzynski S.M., Mogenson G.J. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens. Brain Res. 334(1):1985;77-84.
6. Canales J.J., Iversen S.D. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors. Synapse. 36(4):2000;297-306.
7. Chan C.F., Lin-Shiau S.Y. Suramin prevents cerebellar granule cell-death induced by dequalinium. Neurochem. Int. 38(2):2001;135-143.
8. Costall B., Naylor R.J. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines. J. Med. Chem. 20(2):1977;190-196.
9. Dale N., Gilday D. Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos. Nature. 383(6597):1996;259-263.
10. Dall'olio R., Rimondini R., Gandolfi O. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats. Pharmacol. Res. 36(3):1997;203-209.
11. Dunwiddie T.V., Diao L., Proctor W.R. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci. 17(20):1997;7673-7682.
12. Frantz K., Van Hartesveldt C. The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats. Eur. J. Pharmacol. 368(2/3):1999;125-135.
13. Fuller T.A., Russchen F.T., Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J. Comp. Neurol. 258(3):1987;317-338.
14. Geyer M.A., Russo P.V., Masten V.L. Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol. Biochem. Behav. 25(1):1986;277-288.
15. Gong W., Neill D.B., Lynn M., Justice J.B. Jr. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience. 93(4):1999;1349-1358.
16. Gu J.G., Bardoni R., Magherini P.C., MacDermott A.B. Effects of the P2-purinoceptor antagonists suramin and pyridoxal-phosphate-6-azophenyl- 2′,4′-disulfonic acid on glutamatergic synaptic transmission in rat dorsal horn neurons of the spinal cord. Neurosci. Lett. 253(3):1998;167-170.
17. 3H ]acetylcholine release by striatal glutamate and dopamine receptors Brain Res. 844(1/2):1999;106-117.
18. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41(1):1991;89-125.
19. Horvitz J.C., Williams G., Joy R. Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion. Psychopharmacology (Berlin). 154(4):2001;350-355.
20. Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience. 113(4):2002;939-955.
21. Jones D.L., Mogenson G.J. Nucleus accumbens to globus pallidus GABA projection: electrophysiological and iontophoretic investigations. Brain Res. 188(1):1980;93-105.
22. Kalivas P.W., Alesdatter J.E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267(1):1993;486-495.
23. Kelly P.H. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Brain Res. 100(1):1975;163-169.
24. Kittner H., Franke H., Fischer W., Schultheis N., Krügel U., Illes P. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze; implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology. 28:2003;435-444.
25. Kittner H., Krügel U., Hoffmann E., Illes P. Effects of intra-accumbens injection of 2-methylthio ATP: a combined open field and electroencephalographic study in rats. Psychopharmacology (Berlin). 150(2):2000;123-131.
26. Kittner H, Krügel U, Hoffmann E, Illes P. Stimulation of P2Y receptors enhances feeding behaviour in rats. Naunyn Schmiedebergs Arch Pharmacol 2001;363(Suppl 4):R33, 118.
27. Kolasiewicz W., Maj J. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849. Pol. J. Pharmacol. 48(5):1996;467-479.
28. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242(4879):1988;715-723.
29. Koos T., Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2(5):1999;467-472.
30. Krügel U., Kittner H., Illes P. Adenosine 5′-triphosphate- induced dopamine release in the rat nucleus accumbens in vivo. Neurosci. Lett. 265(1):1999;49-52.
31. Krügel U., Kittner H., Illes P. Mechanisms of adenosine 5′-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Synapse. 39(3):2001;222-232.
32. Krügel U, Regenthal R, Kittner H, Illes P. P2 receptor-evoked glutamate release in the nucleus accumbens is mediated by dopamine. Naunyn Schmiedebergs Arch Pharmacol 2002;365(Suppl):R32, 114.
33. Maldonado-Irizarry C.S., Kelley A.E. Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions. Psychopharmacology (Berlin). 116(1):1994;65-72.
34. Masaki E., Yamazaki K., Ohno Y., Nishi H., Matsumoto Y., Kawamura M. The anesthetic interaction between adenosine triphosphate and N-methyl-D-aspartate receptor antagonists in the rat. Anesth. Analg. 92:2001;134-139.
35. Mele A., Castellano C., Felici A., Cabib S., Caccia S., Oliverio A. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice. Eur. J. Pharmacol. 308(1):1996;1-12.
36. Mele A., Thomas D.N., Pert A. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity. Neuroscience. 82(1):1998;43-58.
37. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14(2/3):1980;69-97.
38. Mogenson G.J., Wu M. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res. 551(1/2):1991;216-220.
39. Motin L., Bennett M.R. Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus. Br. J. Pharmacol. 115(7):1995;1276-1280.
40. Ouagazzal A., Nieoullon A., Amalric M. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur. J. Pharmacol. 251(2/3):1994;229-236.
41. Paxinos G. In: Watson C, editor. The rat brain stereotaxic coordinates. San Diego: Academic Press; 1986.
42. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14(3):1985;149-167.
43. Pennartz C.M., Boeijinga P.H., Lopes da Silva F.H. Locally evoked potentials in slices of the rat nucleus accumbens: NMDA and non-NMDA receptor mediated components and modulation by GABA. Brain Res. 529(1/2):1990;30-41.
44. Pijnenburg A.J., van Rossum J.M. Letter: stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmacol. 25(12):1973;1003-1005.
45. Pulvirenti L., Berrier R., Kreifeldt M., Koob G.F. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat. Brain Res. 664(1/2):1994;231-236.
46. Robbins T.W., Cador M., Taylor J.R., Everitt B.J. Limbic-striatal interactions in reward-related processes. Neurosci. Biobehav. Rev. 13(2/3):1989;155-162.
47. Segovia G., Del Arco A., Mora F. Effects of aging on the interaction between glutamate, dopamine, and GABA in striatum and nucleus accumbens of the awake rat. J. Neurochem. 73(5):1999;2063-2072.
48. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22(11):1999;521-527.
49. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol. Biochem. Behav. 58(4):1997;933-945.
50. Swerdlow N.R., Swanson L.W., Koob G.F. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens. Brain Res. 306(1/2):1984;141-148.
51. Thiel C.M., Müller C.P., Huston J.P., Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience. 93(1):1999;243-251.
52. Van Hartesveldt C., Cottrell G.A., Potter T., Meyer M.E. Effects of intracerebral quinpirole on locomotion in rats. Eur. J. Pharmacol. 214(1):1992;27-32.
53. Vigne P., Pacaud P., Urbach V., Feolde E., Breittmayer J.P., Frelin C. The effect of PPADS as an antagonist of inositol (1,4,5)trisphosphate induced intracellular calcium mobilization. Br. J. Pharmacol. 119(2):1996;360-364.
54. Windscheif U., Pfaff O., Ziganshin A.U., Hoyle C.H., Baumert H.G., Mutschler E.et al. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig tania coli and rat duodenum. Br. J. Pharmacol. 115(8):1995;1509-1517.
55. Wirkner K., Köles L., Thümmler S., Luthardt J., Poelchen W., Franke H.et al. Interaction between P2Y and NMDA receptors in layer V pyramdial neurons of the rat prefrontal cortex. Neuropharmacology. 42(4):2002;476-488.
56. Wise R.A. Neural mechanisms of the reinforcing action of cocaine. NIDA Res. Monogr. 50:1984;15-33.
57. Wu M., Brudzynski S.M., Mogenson G.J. Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion. Can. J. Physiol. Pharmacol. 71(5/6):1993;407-413.
58. Yoshida M., Yokoo H., Tanaka T., Emoto H., Tanaka M. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636(1):1994;111-114.